Figure 1.
Pathological pathways of AD and potential sites of therapeutic intervention. It is hypothesized that Aβ plays the most important role in the initiation of the neuropathogenesis of AD. Other factors
also contribute to the onset and progress of the disease. Amyloid plaques and neurofibrillary tangles are hallmarks of the
disease. Therapies that might reduce Aβ production, mitigate plaque formation, or otherwise interfere with the progression
of AD are indicated in blue.